Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors
- Details
- Category: Research
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
The drug combination, which blocked an overactive cell-growth signaling pathway, shrank tumors by 50% or more in one-third of 45 patients with hard-to-treat high-grade gliomas, including glioblastomas, the most aggressive brain tumor.
Aspirin is linked with increased risk of heart failure
- Details
- Category: Research
Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC). Predisposing factors included smoking, obesity, high blood pressure, high cholesterol, diabetes, and cardiovascular disease.
Exposure to harmless coronaviruses boosts SARS-CoV-2 immunity
- Details
- Category: Research
The population's immunity to SARS-CoV-2, achieved either through infection or vaccination, is crucial to overcome the COVID-19 pandemic. A team of researchers led by the University of Zurich (UZH) has now discovered another component that contributes to SARS-CoV-2 immunity - previous antibody responses to other, harmless coronaviruses.
Repurposing a familiar drug for COVID-19
- Details
- Category: Research
For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day, hundreds of thousands of new COVID-19 cases and thousands of new deaths are still being reported worldwide, creating a need for drugs that can combat the disease caused by SARS-CoV-2.
Scientists identify new types of a blood cancer and potential targeted treatments
- Details
- Category: Research
Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma. They also identified potential targeted treatments based on the findings, as reported in Science Advances in November.
Coffee and tea drinking may be associated with reduced rates of stroke and dementia
- Details
- Category: Research
Drinking coffee or tea may be associated with a lower risk of stroke and dementia, according to a study of healthy individuals aged 50-74 publishing November 16th in the open-access journal PLOS Medicine. Drinking coffee was also associated with a lower risk of post-stroke dementia.
'Dancing molecules' successfully repair severe spinal cord injuries
- Details
- Category: Research
Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries.
In a new study, researchers administered a single injection to tissues surrounding the spinal cords of paralyzed mice. Just four weeks later, the animals regained the ability to walk.
More Pharma News ...
- New target for COVID-19 vaccines identified
- A target for potential cancer drugs may, in fact, worsen disease
- Safety concerns raised for neuroblastoma candidate drug
- Study offers insights on why the elderly are more susceptible to COVID-19
- Finding a new purpose for old drugs: Researchers have found promising drugs for COVID-19
- Novel drug liberates tumour vessels to aid cancer drug delivery
- Researchers reveal a strategy for next-generation COVID-19 vaccines